 NEW YORK, May 04, 2022 GLOBE NEWSWIRE -- atai Life Sciences N.V. Nasdaq: ATAI atai, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will announce its first-quarter 2022 financial results by posting them on the IR portion of its website. Please visit the atai investor relations website at to view Q122 financial results and press release. 